289 related articles for article (PubMed ID: 37671151)
1. How single-cell techniques help us look into lung cancer heterogeneity and immunotherapy.
Liao P; Huang Q; Zhang J; Su Y; Xiao R; Luo S; Wu Z; Zhu L; Li J; Hu Q
Front Immunol; 2023; 14():1238454. PubMed ID: 37671151
[TBL] [Abstract][Full Text] [Related]
2. Spatial profiling of the microenvironment reveals low intratumoral heterogeneity and STK11-associated immune evasion in therapy-naïve lung adenocarcinomas.
Goldschmid H; Kluck K; Ball M; Kirchner M; Allgäuer M; Winter H; Herth F; Heußel CP; Pullamsetti SS; Savai R; Yong TTK; Schirmacher P; Peters S; Thomas M; Christopoulos P; Budczies J; Stenzinger A; Kazdal D
Lung Cancer; 2023 Jun; 180():107212. PubMed ID: 37141769
[TBL] [Abstract][Full Text] [Related]
3. Promising immunotherapeutic targets in lung cancer based on single-cell RNA sequencing.
Xue Q; Peng W; Zhang S; Wei X; Ye L; Wang Z; Xiang X; Zhang P; Zhou Q
Front Immunol; 2023; 14():1148061. PubMed ID: 37187731
[TBL] [Abstract][Full Text] [Related]
4. Emerging organoid-immune co-culture models for cancer research: from oncoimmunology to personalized immunotherapies.
Magré L; Verstegen MMA; Buschow S; van der Laan LJW; Peppelenbosch M; Desai J
J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37220953
[TBL] [Abstract][Full Text] [Related]
5. Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer.
Jin R; Liu C; Zheng S; Wang X; Feng X; Li H; Sun N; He J
Cancer Biol Med; 2020 Aug; 17(3):768-781. PubMed ID: 32944405
[No Abstract] [Full Text] [Related]
6. Roles of immune microenvironment heterogeneity in therapy-associated biomarkers in lung cancer.
Wang L; Zhu B; Zhang M; Wang X
Semin Cell Dev Biol; 2017 Apr; 64():90-97. PubMed ID: 27639893
[TBL] [Abstract][Full Text] [Related]
7. [Research Progress of Single Cell Sequencing in Lung Cancer].
Yu M; Tan J; Wang J
Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):279-283. PubMed ID: 33910276
[TBL] [Abstract][Full Text] [Related]
8. [Correlation between Immune Microenvironment Features and EGFR Mutation Status
in Lung Adenocarcinoma].
Zhu H; Chen P; Dong G; Meng F; Xia Z; You J; Kong X; Wu J; Yuan F; Yu X; Sun Q; Ji J; Wang S; Liu T; Xu L
Zhongguo Fei Ai Za Zhi; 2023 Mar; 26(3):204-216. PubMed ID: 37035883
[TBL] [Abstract][Full Text] [Related]
9. Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma.
Yang L; He YT; Dong S; Wei XW; Chen ZH; Zhang B; Chen WD; Yang XR; Wang F; Shang XM; Zhong WZ; Wu YL; Zhou Q
J Immunother Cancer; 2022 Jan; 10(2):. PubMed ID: 35140113
[TBL] [Abstract][Full Text] [Related]
10. Deciphering colorectal cancer immune microenvironment transcriptional landscape on single cell resolution - A role for immunotherapy.
Tieng FYF; Lee LH; Ab Mutalib NS
Front Immunol; 2022; 13():959705. PubMed ID: 36032085
[TBL] [Abstract][Full Text] [Related]
11. Psychological distress influences lung cancer: Advances and perspectives on the immune system and immunotherapy.
Gui H; Chen X; Li L; Zhu L; Jing Q; Nie Y; Zhang X
Int Immunopharmacol; 2023 Aug; 121():110251. PubMed ID: 37348230
[TBL] [Abstract][Full Text] [Related]
12. Single-cell spatial landscape of immunotherapy response reveals mechanisms of CXCL13 enhanced antitumor immunity.
Sorin M; Karimi E; Rezanejad M; Yu MW; Desharnais L; McDowell SAC; Doré S; Arabzadeh A; Breton V; Fiset B; Wei Y; Rayes R; Orain M; Coulombe F; Manem VSK; Gagne A; Quail DF; Joubert P; Spicer JD; Walsh LA
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36725085
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy for Neuro-oncology.
Majd NK; Dasgupta PR; de Groot JF
Adv Exp Med Biol; 2021; 1342():233-258. PubMed ID: 34972967
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of tumor immune microenvironment and real-world analysis of immunotherapy efficacy in lung adenosquamous carcinoma.
Li C; Zheng X; Li P; Wang H; Hu J; Wu L; Wang Z; Guo H; Wu F; Zhong W; Zhou C; Chu Q; Zhao J; Zheng X; Xiao W; Zhu W; Zhang L; Li Q; Jiang K; Miao Q; Wu B; Xu Y; Wu S; Wang H; Yang S; Li Y; Xia X; Yi X; Huang C; Zhu B; Lin G
Front Immunol; 2022; 13():944812. PubMed ID: 36032124
[TBL] [Abstract][Full Text] [Related]
15. Natural killer cell‑based immunotherapy for lung cancer: Challenges and perspectives (Review).
Zeng Y; Lv X; Du J
Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34498710
[TBL] [Abstract][Full Text] [Related]
16. Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer.
Deng JY; Gou Q; Yang L; Chen ZH; Yang MY; Yang XR; Yan HH; Wei XW; Liu JQ; Su J; Zhong WZ; Xu CR; Wu YL; Zhou Q
J Immunother Cancer; 2023 Jul; 11(7):. PubMed ID: 37463790
[TBL] [Abstract][Full Text] [Related]
17. Immune Therapy.
Lievense L; Aerts J; Hegmans J
Adv Exp Med Biol; 2016; 893():59-90. PubMed ID: 26667339
[TBL] [Abstract][Full Text] [Related]
18. Overview of Lung Cancer Immunotherapy.
Sanmamed MF; Eguren-Santamaria I; Schalper KA
Cancer J; 2020; 26(6):473-484. PubMed ID: 33298718
[TBL] [Abstract][Full Text] [Related]
19. The single-cell transcriptional landscape of lung carcinoid tumors.
Bischoff P; Trinks A; Wiederspahn J; Obermayer B; Pett JP; Jurmeister P; Elsner A; Dziodzio T; Rückert JC; Neudecker J; Falk C; Beule D; Sers C; Morkel M; Horst D; Klauschen F; Blüthgen N
Int J Cancer; 2022 Jun; 150(12):2058-2071. PubMed ID: 35262195
[TBL] [Abstract][Full Text] [Related]
20. [Immunotherapy in non-small cell lung cancer patients: back to the future.].
Roberto M; Botticelli A; Cecere F; Cognetti F; Giusti R; Gelibter A; Lugini A; Nelli F; Nuti M; Santini D; Marchetti P
Recenti Prog Med; 2019 Dec; 110(12):587-593. PubMed ID: 31909761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
